Does Mounjaro Cause Depression or Anxiety?

What tirzepatide's clinical trial programme found, and what it did not

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed 2,539 adults over 72 weeks and was the primary basis for Mounjaro's weight-management licence. Across that programme, the most frequently reported side effects were gastrointestinal, nausea, diarrhoea, constipation and vomiting, particularly around dose increases. Depression and anxiety did not emerge as signals at a rate that classified them as common or uncommon adverse reactions in the trial safety data. The NHS tirzepatide medicines page reflects this: it does not list depression or anxiety among the recognised side effects, though it does note that any new mental health symptoms should be taken seriously and discussed with a prescriber.

That absence of a causal signal is reassuring, but it is not a guarantee for any individual. Large trials capture averages; your experience may differ, and the UK's prescribing framework is set up to catch exactly that. The MHRA's Black Triangle designation for Mounjaro (meaning additional surveillance is ongoing) exists partly so that post-market signals, including rare or delayed ones, are picked up as more people use the medicine in real-world conditions. If you notice something that troubles you, reporting it via the Yellow Card scheme contributes to that picture.

Why mood can shift during weight-loss treatment, and when Mounjaro may play a role

Significant weight loss is a physiological event. Appetite suppression from tirzepatide means many people eat far less than they used to, and if protein and fluid intake fall too low, fatigue, low mood and poor concentration can follow. Neither the medicine nor mood change alone tells the full story, the combination of restricted eating, disrupted energy and sleep changes can look a lot like anxiety or low mood even without a direct pharmacological cause. If you are wondering whether the medicine itself could be responsible, our page on whether Mounjaro can cause anxiety looks at what the evidence actually shows.

Dose escalation is another point worth watching. Some people report a window of heightened unease or irritability in the days after moving to a higher strength, while the body adjusts. This tends to settle. But if it does not, or if it worsens, that is information for your prescriber, not something to push through alone. Our full overview of Mounjaro side effects covers the broader picture of what is expected and what warrants attention.

There is also a less obvious possibility: for some people, losing weight quickly brings a complicated emotional response. Body-image adjustment, changes in how others treat you, or an unmasking of feelings that food previously helped to manage can all surface. Worth being honest with yourself about that, it takes under a minute to notice whether what you are feeling has more to do with your mood or your stomach, and that distinction helps your prescriber.

Who should have a careful conversation before starting

The Mounjaro SmPC and NHS guidance both flag that people with a current or past history of severe depression, an eating disorder, or suicidal ideation need a thorough discussion with their prescriber before starting treatment. This is not a blanket exclusion, it is a prompt for a more careful assessment. The prescriber will want to understand how stable that history is, what support is in place and whether tirzepatide is the right fit at this point. If you are curious about how that assessment works in practice, our Mounjaro treatment page describes the clinical process.

For those already on antidepressants or anxiolytics, the main consideration is whether GLP-1-related slower gastric emptying could affect how those medicines are absorbed. This is a nuanced question for your prescriber, not a reason to avoid treatment automatically. Similarly, the tirzepatide-specific note about oral contraceptives and absorption applies to other oral medicines too, something our prescribers factor into every review. If this is your situation, you can explore it further on the page looking at whether tirzepatide causes anxiety, which goes into the mechanism in more detail.

How to raise mood concerns, and what to do if they arise mid-treatment

If you are already on Mounjaro and have noticed low mood, anxiety, or a shift in how you are feeling emotionally, do not let it sit. Contact your prescriber or GP, not next month, this week. Our page on Mounjaro side effects and depression is a useful starting point for understanding what to look out for and when to seek help. Serious symptoms, including thoughts of self-harm or harming others, warrant urgent help from your GP or, if needed, a mental health crisis line.

At nume, aftercare is available seven days a week. Every repeat order goes through clinical re-review, which means your prescriber sees your current picture before anything is dispensed again. That is a designed-in check, not a formality. If you have questions that do not fit neatly into a repeat-order conversation, our contact page is the quickest route to the clinical team.

Mental health is one of the things our prescribers take into account from the very first consultation. If you have not yet started treatment and you are wondering how a mood history would be handled, the best way to find out is to begin a free consultation and let a prescriber review your full picture. It is a conversation, not a form. If you would like to read more before speaking to anyone, our page explaining why Mounjaro may cause anxiety in some people covers the physiological background in plain language.